Clal Insurance Enterprises (CLIS) Q1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2024 earnings summary
10 Nov, 2026Executive summary
Q1 2024 net income was NIS 42 million versus a NIS 88 million loss; comprehensive income was NIS 165 million, including NIS 164 million attributable to shareholders, versus losses of NIS 101 million and NIS 102 million, respectively.
Stronger capital markets and P&C underwriting supported results; lower life premiums, health-sector LAT charges and a one-time NIS 18 million tax expense partly offset gains.
The 2023 Max acquisition broadened activities into credit cards alongside insurance and long-term savings; Max and Milo results were consolidated from Q2 2023, affecting comparisons.
Financial highlights
Total income was NIS 7,536 million versus NIS 4,081 million; investment and finance income was NIS 4,551 million versus NIS 1,227 million, with comparisons affected by Max consolidation timing.
Income before tax was NIS 79 million versus a NIS 141 million loss; income attributable to shareholders was NIS 41 million versus a NIS 89 million loss. Basic EPS was NIS 0.51 versus a NIS 1.20 loss.
Premiums, contributions and proceeds totaled NIS 6.5 billion versus NIS 6.7 billion; assets under management were NIS 348 billion at March 31, up from NIS 338 billion at year-end.
Shareholders’ equity attributable to shareholders was NIS 8.7 billion; general, administrative and operating expenses plus commissions were NIS 796 million versus NIS 794 million.
Outlook and guidance
No full-year earnings guidance was stated; the effects of market developments on Q2 and FY 2024 could not be assessed.
Variable management fees on participating life policies remain unavailable until accumulated investment losses are recovered; the foregone fee liability was NIS 0.4 billion at March 31 and NIS 0.5 billion shortly before publication.
Dividend policy targets distribution of 30%–50% of comprehensive income, conditional on maintaining a 110% minimum solvency ratio without transitional provisions after distribution; this is not a commitment to pay dividends.
Latest events from Clal Insurance Enterprises
- H1 returned to profit on stronger underwriting and card results despite weak markets.CLIS
Q2 2024 - 9M comprehensive income reached NIS 596m, supported by stronger investment returns and underwriting.CLIS
Q3 2024 - 2024 comprehensive income rose to NIS 956m as insurance and MAX expanded earnings.CLIS
Q4 2024 - Q1 earnings rose on stronger underwriting and Max, amid market and war-related uncertainty.CLIS
Q1 2025 - H1 core income rose modestly as strong insurance results met Q2 softness and a VAT provision.CLIS
Q2 2025 - 9M earnings and AUM grew, with results absorbing a one-off VAT provision.CLIS
Q3 2025 - Core income rose 12%; 2025 dividend reached NIS 400M.CLIS
Q4 2025 - Core income rose 13% as insurance and savings growth lifted Q1 results.CLIS
Q1 2026 - H1 earnings and AUM grew, alongside NIS 200M buyback and dividend plans.CLIS
Q2 2026